Search

everythinglearnresearchcommunity

for

Search:↓

Some psychiatric drugs can cause severe hair loss, especially valproic acid, and it's more likely in women or those with thyroid issues or past hair loss.

The decision tree can predict drug absorption issues with good accuracy but needs more validation and adjustments for other factors.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Most injecting drug users in the study had hepatitis C and skin problems, which moderately affected their quality of life.

Machine learning identified three unique subtypes of androgen excess in women with PCOS, each with different metabolic risks.

Levofloxacin may cause skin discoloration and hair loss as side effects.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Blood pressure medications may increase the risk of skin cancer.

Drinking alcohol before taking flibanserin does not increase the risk of severe low blood pressure or fainting.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

Low alternating doses of sodium divalproate reduced migraine frequency but caused weight gain.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Early detection of chemotherapy side effects allows treatment adjustments, improving patient outcomes.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Increasing olanzapine caused hair loss in a woman, which stopped after changing medication.

Low-dose oral minoxidil effectively promotes hair growth but has associated risks.

Health warnings and public health actions led to a significant drop in flutamide prescriptions for women, but off-label use still continues.

Objective assessment is needed to accurately determine medication use and adherence.

Negative expectations can cause adverse effects in patients even without active treatment, and managing this nocebo effect involves better communication and patient-clinician relationships.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

The lecture concluded that drugs for human enhancement are here to stay and called for their responsible development and fair access.

MK-5108 is safe and shows potential against tumors, especially alone.

Severe digestive issues in DRESS need early endoscopy for better treatment.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Skin ulcers from interferon may not depend on the amount given.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Bortezomib chemotherapy can cause temporary skin rashes.